Social Media Press Releases

RSS

Showing Press Releases with Tag: lupus

10/15/2009

MEDIMMUNE HIGHLIGHTS INFLAMMATORY DISEASE PORTFOLIO AT 73RD ANNUAL MEETING OF THE AMERICAN COLLEGE OF RHEUMATOLOGY

» read more
12/07/2007

AstraZeneca Presents its Global Biologics Organisation, MedImmune, at 2007 Analyst and Investor R&D Day

» read more
4/18/2007

MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases

» read more
4/02/2007

MedImmune Promotes Three Leaders in Key Scientific & Medical Roles

» read more
3/23/2007

MedImmune Expands Anti-Interferon-Alpha Program by Initiating Phase 1 Trial in Patients With Psoriasis

» read more
3/16/2007

MedImmune Leases Human Genome Sciences Facility to Expand Cell Culture Influenza Vaccine Manufacturing Capabilities

» read more
12/28/2006

MedImmune In-Licenses Novel Inflammatory Disease Target

» read more
9/29/2006

MedImmune Named One of Maryland’s Fastest Growing Technology Companies in Deloitte Technology Fast 50 Program

» read more
4/20/2006

MedImmune Reports Financial Results for First Quarter 2006

» read more
4/13/2006

MedImmune Begins Dosing of Lupus Patients in Phase 1 Clinical Trial

» read more
10/20/2005

MedImmune Reports 2005 Third Quarter and Nine-Month Financial Results

» read more
10/13/2005

MedImmune and Medarex Announce Filing of Investigational New Drug Application for Monoclonal Antibody for the Treatment of Lupus

» read more
9/14/2005

MedImmune to Acquire Cellective Therapeutics, Inc.

» read more